AE

Aera Therapeutics

6 known investors

aeratx.com ↗

Aera Therapeutics develops genetic medicines using next-generation delivery technologies and precision payloads optimized for specific diseases. The company focuses on advancing transformative treatments in areas including oncology, rare genetic diseases, and cell therapies.

Founders & leadership

AA

Akin Akinc, Ph.D.CEO

Investors · 6

AR

ARCH Venture Partners✓ verifiedChicago · $50K – $250M

LU

Lux Capital✓ verifiedNew York · $100K – $100M

F-

F-Prime Capital PartnersCambridge · $3M – $10M

GV

GV (Google Ventures)Mountain View · $250K – $50M

JD

JDRF T1D FundBoston

NE

Newpath PartnersreportedBoston · $50K – $10M